Research Article

Toll-Like Receptor Ligand-Induced Liver Injury in D-Galactosamine-Sensitized Mice: Differences between TLR7/8 and TLR9 Ligands, Cytokine Patterns, and Cross-Tolerance Induction by TLR2 Ligand Pretreatment

Table 3

Serum levels of cytokines (pg/ml) in a set of experiments with C57BL/6 mice. Mean ± SD is shown.

CytokineTimePBSCpG/D-galNR848/D-galN
()LTA− ()LTA+ ()LTA− ()LTA+ ()

ALT (U/l)68 ± 13
(10 h)
17875.7 ± 5156.2
(7.5–10 h)
202.4 ± 108.2
(10 h)
14737.5 ± 3894.0
(6–8.5 h)
10112.1 ± 5229.2
(8-10 h)

TNF-α5 h1.5 ± 0.322.7 ± 21.07.3 ± 0.515.5 ± 10.89.6 ± 3.4
10 hn.t.39.8 ± 13.03.0 ± 0.0Not available (death)n.t.

IL-61 h2.4 ± 1.61984.7 ± 771.467.7 ± 29.71029.4 ± 927.3668.6 ± 481.5
5 h2.1 ± 0.81270.5 ± 1199.0112.5 ± 51.4297.7 ± 210.9359.4 ± 294.2
10 hn.t.4424.81 ± 3718.733.2 ± 24.8Not available (death)n.t.

INF-γ1 h1.4 ± 0.61.3 ± 0.51.6 ± 1.21.1 ± 0.61.5 ± 0.5
5 h1.3 ± 0.789.5 ± 74.613.7 ± 5.452.8 ± 33.154.0 ± 9.4
10 hn.t.128.51 ± 147.26.5 ± 4.8Not available (death)n.t.

IL-101 hn.t.23.7 ± 18.66.2 ± 8.36.9 ± 4.32.7 ± 1.7
5 hn.t.90.2 ± 93.163.2 ± 62.026.6 ± 10.86.4 ± 4.7
10 hn.t.270.01 ± 249.52.0 ± 0.0Not available (death)n.t.

IL-17A1 hn.t.2.1 ± 1.12.4 ± 2.21.75 ± 1.02.0 ± 1.3
5 hn.t.2.6 ± 2.14.9 ± 3.51.1 ± 0.82.7 ± 0.8
10 hn.t.1.01 ± 0.61.0 ± 0.0Not available (death)n.t.

IL-231 hn.t.16.7 ± 3.410.5 ± 3.712.4 ± 4.714.3 ± 7.4
5 hn.t.15.0 ± 4.616.5 ± 3.79.4 ± 3.816.7 ± 3.4
10 hn.t.18.31 ± 8.39.0 ± 0.0Not available (death)n.t.

IL-271 hn.t.4.6 ± 2.57.5 ± 5.02.6 ± 1.44.7 ± 2.6
5 hn.t.8.2 ± 4.611.0 ± 8.23.1 ± 1.510.3 ± 5.6
10 hn.t.5.51 ± 3.02.4 ± 1.1Not available (death)n.t.

n.t.: not tested. PBS (LTA− mice) or 200 μg/mouse LTA (LTA+ mice) was administered 24 h prior to the challenge with the 20 μg CpG (or 10 μg R848)/20 μg D-galN. Asterisks indicate a significant difference between with and without the LTA pretreatment (, , and ). 1Two out of seven mice died within 10 h, and the five mice that survived within 10 h were analyzed.